Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

What is Cancer?

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Single-cell DNA methylation analysis uncovers epigenetic pathways in the transformation of MDS to AML.

Leukemia·2026

Same author

Imaging the hallmarks of cancer.

Nature reviews. Cancer·2026

Same author

Cellular assembly and functional resilience of the mammalian RNA exosome.

The EMBO journal·2026

Same author

Longitudinal changes in DNA methylation in IDH-mutant glioma fuel disease progression through altered cell state differentiation.

Nature genetics·2026

Same author

Stromal cell subsets modulate T-cell infiltration in early breast cancer.

Cancer research communications·2026

Same author

Spatial epitranscriptomics: from Cinderella to queen.

Nature methods·2026

Same journal

DNA, Peptide Vaccines Advance Against GBM.

Cancer discovery·2026

Same journal

AKR1C1 Promotes ADC Resistance by Altering Uptake and Export.

Cancer discovery·2026

Same journal

Acquisition of Centromeric Features Supports Telomere Integrity.

Cancer discovery·2026

Same journal

Germline CDK12 variants in aggressive prostate cancer.

Cancer discovery·2026

Same journal

Type II JAK2 Inhibitor Gets Off to a Strong Start.

Cancer discovery·2026

Same journal

Pancreatic Cancer: Translating Tumor Biology into Actionability.

Cancer discovery·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 9, 2025

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

Cancer Evolution: A Multifaceted Affair.

Giovanni Ciriello^1,2, Luca Magnani^3,4,5, Sarah J Aitken^6,7

¹Swiss Cancer Center Leman, Lausanne, Switzerland.

Cancer Discovery

|December 4, 2023

Summary

This summary is machine-generated.

Cancer evolution involves genetic and nongenetic changes, including epigenetic modifications and tumor microenvironment interactions. Understanding these interconnected mechanisms is key for personalized cancer medicine and biomarker discovery.

More Related Videos

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Related Experiment Videos

Last Updated: Jul 9, 2025

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

Cancer cells evolve through molecular modifications, a process termed cancer evolution.
Traditional focus on genetic changes offers insights, but nongenetic mechanisms like epigenetics and tumor microenvironment interactions are also crucial.
Cancer hallmarks arise from a complex interplay of genetic and nongenetic factors.

Purpose of the Study:

To provide a comprehensive characterization of the cancer evolutionary toolkit.
To highlight the multifaceted nature of tumor evolution.
To emphasize the need for integrated approaches to understand, predict, and steer tumor evolution.

Main Methods:

Review of theoretical frameworks for cancer evolution.
Analysis of recent findings on tumor evolutionary mechanisms.
Integration of genetic, epigenetic, and microenvironment interaction data.

Main Results:

Cancer evolution is driven by multiple, interacting mechanisms, not just genetic instability.
Epigenetic reprogramming and tumor microenvironment interactions significantly contribute to cancer progression.
Heterogeneous forces interact dynamically to shape tumor development.

Conclusions:

A comprehensive understanding of the cancer evolutionary toolkit is essential for advancing personalized medicine and biomarker discovery.
Experimental and theoretical approaches must consider the interplay of multiple evolutionary mechanisms.
Accounting for these interactions is vital to ultimately understand, predict, and steer tumor evolution.